CClinicalTrials.gg
Not yet recruitingNCT06441734Updated Jul 16, 2024

Iron Status in Autism Spectrum Disorders

An observational study in Anemia, Iron Deficiency, sponsored by Assiut University. Not yet recruiting. Open to participants aged 2 Years to 12 Years. Per ClinicalTrials.gov, last updated 2024-07-16.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
46
Ages
2 Years to 12 Years
Sex
All
01

Study summary

to evaluate the prevalence of iron deficiency anemia in group with autism spectrum disorders in comparison to normal children group

02

Conditions studied

03

In context

Anemia, Iron-Deficiency

644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.

This study's planned enrollment of 46 is below the median of 200 across 113 observational studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 12 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

children age from 2years to 12 years not having an infection or inflammatory conditions or physical illness

Inclusion criteria

  • children who are diagnosed with autism spectrum disorder according to DSM -V
  • not having infection inflammatory conditions chronic physical illness
  • children who are not receiving iron supplementation

Exclusion criteria

Exclusion Criteria:

  • age below 2 years and above 12 years
  • having an infection or inflammatory conditions chronic physical illness
  • receiving iron supplementation
05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
46 participants (estimated)
Patient registry
No

Groups and cohorts

  • study group

    Diagnostic Test: cbc serum ferritin serum iron

  • control group

    Diagnostic Test: cbc serum ferritin serum iron

Interventions

  • Diagnostic testcbc serum ferritin serum iron

    by using sample of blood to do cbc and serum ferritin and serum iron during 1year

06

What researchers measure

Primary outcomes

  1. iron status in autism spectrum disorders

    by cbc serum ferritin serum iron

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Al-Beltagi M. Autism medical comorbidities. World J Clin Pediatr. 2021 May 9;10(3):15-28. doi: 10.5409/wjcp.v10.i3.15. eCollection 2021 May 9. PubMed 33972922 ↗

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06441734
Lead sponsor
Assiut University
Responsible party
esraa hefzy shaker mostafa (principle investigator, Assiut University) — Principal investigator
First posted
Jun 4, 2024
Start date
Aug 2, 2024 (estimated)
Primary completion
Jun 2, 2025 (estimated)
Completion
Jul 2025 (estimated)
Last update
Jul 16, 2024

Study contacts

esraa hefzy shaker
Contact
esraahefzy31@gmail.com
01090930692
emad eldeen mahmoud hammad, professor
Contact
01223559943
khalaf abdelaal said, lecturer
study chair · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion